Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
PHAR Pharming Group
- 8.960
- +0.210+2.40%
Close May 2 16:00 ET
612.80MMarket Cap-49.78P/E (TTM)
9.384High8.950Low3.43KVolume9.190Open8.750Pre Close31.04KTurnover0.01%Turnover RatioLossP/E (Static)68.39MShares11.07052wk High2.77P/B581.57MFloat Cap6.65052wk Low--Dividend TTM64.91MShs Float21.990Historical High--Div YieldTTM4.96%Amplitude6.100Historical Low9.044Avg Price1Lot Size
About Pharming Group Company
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST?, Joenja?, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Company Profile
SymbolPHAR
Company NamePharming Group
Issue Price19.19
Founded2019
CEOMr. Fabrice Chouraqui, M.B.A.,Pharm.D.
MarketNASDAQ
Employees404
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends12-31
AddressVondellaan 47
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2332 AA
Phone31-71-524-74-00
Websitehttp://www.pharming.com
Company Executives
- Name
- Position
- Salary
- Fabrice Chouraqui, M.B.A.,Pharm.D.
- Executive Director and Chief Executive Officer
- --
- Mireille Sanders, M. Sc.
- Chief Operations Officer
- --
- Ines Bernal
- Chief People Officer
- --
- Stephen Toor
- Chief Commercial Officer
- --
- Ruud van Outersterp
- Chief Ethics and Compliance Officer
- --
- Jeroen Wakkerman
- Chief Financial Officer
- --
- Dr. Anurag Relan, M.D.
- Chief Medical Officer
- --
- Dr. Alexander Breidenbach, PhD
- Chief Business Officer
- --
- Deborah A. Jorn, M.B.A.
- Vice Chairman of the Board
- 87.00K
- Barbara Yanni
- Director
- 94.00K
- Steven Baert
- Director
- 90.00K
- Dr. Mark J. Pykett,PhD,V.M.D.
- Director
- 87.00K
- Jabine van der Meijs
- Independent Director
- 94.00K
- Leonard Kruimer
- Independent Director
- 90.00K
- Dr. Richard Peters, M.D.,PhD
- Chiarman of the Board
- 46.00K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now